The frequency of CD11b+F4/80+ macrophages in total CD45+ cells within spleen represented a similar but weaker trend as in the tumor (Figure 6H), which suggested that CBD–SIRPαFc mainly improved antitumor immunity within the tumor. The gene discussed is PTPRC; the disease is neoplasm.